Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study. Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Recent publications
-
Association between Coeliac disease and Cardiovascular Disease: A prospective analysis in UK Biobank
Journal article
CONROY M. et al, (2023), BMJ Medicine
-
UK Biobank: a globally important resource for cancer research.
Journal article
Conroy MC. et al, (2022), British journal of cancer
-
How UK Biobank is democratising access to large-scale genomic and phenotypic data for discovery science
Journal article
LACEY B. et al, (2022)
-
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia.
Journal article
Watts EL. et al, (2022), International journal of cancer, 151, 1033 - 1046
-
Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses.
Journal article
Dimou N. et al, (2022), Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 31, 1839 - 1848